Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« CDK4/6 inhibition in high-risk early breast cancer Next Article
Amantadine, modafinil, and methylphenidate for MS-related fatigue »
« CDK4/6 inhibition in high-risk early breast cancer Next Article
Amantadine, modafinil, and methylphenidate for MS-related fatigue »
Table of Contents: ESMO 2020
Featured articles
COVID-19 and Cancer
Breast Cancer
Gastrointestinal Cancers
Lung Cancer
Melanoma
Genitourinary Cancers
Bladder cancer risk and early detection
Gynaecological Cancers
Basic Science
Related Articles
November 25, 2020
Rechallenge of RAS/BRAF wildtype CRC with avelumab plus cetuximab
November 25, 2020
New treatment option for patients with mCRPC
November 25, 2020
Preoperative immunotherapy in early stage NSCLC safe and feasible
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy